This study demonstrates metformin's ability to alleviate morphine-induced analgesic tolerance in mice, suggesting a new pain management approach.
Morphine-induced analgesic tolerance limits its clinical use. This study shows that metformin alleviates such tolerance by inhibiting the TXNIP/NLRP3/GSDMD axis, reducing microglial activation and proinflammatory cytokines in CD-1 mice (metformin 200 mg/kg i.p.; morphine 10 mg/kg s.c.) and BV-2 cells (metformin 100 μM; morphine 200 μM). TXNIP is critical, as its overexpression weakens metformin's effect. The TXNIP siRNA/metformin coloaded TM@ZIF-8/HA nanosystem enhances efficacy via pH-responsive, CD44-targeted delivery with good biocompatibility, providing a perioperative pain management strategy.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: